- Brown & Brown‘s adjusted earnings per share (EPS) for the fourth quarter came in at 86 cents, higher than both the previous year’s 58 cents and the estimated 75 cents.
- Organic revenue increased by 13.8%, surpassing the estimated growth of 8.73%.
- Total revenue reached $1.18 billion, marking a 15% increase from the previous year and exceeding the expected $1.12 billion.
- The EBITDAC margin decreased to 33% compared to 43.6% from the previous year.
- Compensation expenses rose by 5.1% to $582 million, which was lower than the projected $592.3 million.
- Analyst recommendations include 8 buys, 6 holds, and 1 sell.
“`
A look at Brown & Brown Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Brown & Brown shows a promising long-term outlook. With a Growth score of 4 and a Momentum score of 4, the company is positioned well for potential expansion and market performance. Additionally, earning a Resilience score of 3 indicates a solid ability to withstand economic challenges. While its Value and Dividend scores are more moderate at 2, the company’s strong focus on growth and momentum bodes well for its future trajectory.
As a company providing insurance, reinsurance, risk management, and employee benefit services across the United States, Brown & Brown is strategically positioned in the market. With a diverse range of offerings and a geographic presence, the company has the potential to capitalize on growth opportunities. Overall, the Smartkarma Smart Scores suggest that Brown & Brown is set to navigate the market with a strong growth outlook and a resilient operational framework.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
